Opt-out

TNKase Dosing and Administration

Investigate the Molecule

Clinical Data

Publications and Resources

Relevant Links

Product Return and Replacement

Prescribing Information

LyticExperience Website


Genentech respects your right to opt out of future communications about TNKase^® (Tenecteplase). Please read our complete Privacy Policy to learn more about our use of your information.

Fields marked with an asterisk (*) are required.
*First name:	*Last name:

*Email address:


By completing and submitting this form you, assert your right to opt out of future TNKase communications.

Indication
For use in mortality reduction associated with acute myocardial infarction (AMI). Treatment should be initiated as soon as possible after the onset of AMI symptoms.

Important Safety Information
TNKase therapy in patients with acute myocardial infarction is contraindicated in the following certain situations (eg, active internal bleeding, history of cerebrovascular accident, known bleeding diathesis, severe uncontrolled hypertension) because of an increased risk of bleeding [See CONTRAINDICATIONS in full prescribing information].

The most common complication encountered during TNKase therapy is bleeding. Should serious bleeding (not controlled by local pressure) occur, any concomitant heparin or antiplatelet agents should be discontinued immediately.

In certain conditions (eg, recent major surgery, cerebrovascular disease, hypertension) the risk of TNKase therapy may be increased and should be weighed against the anticipated benefits. [See WARNINGS in full prescribing information].

Cholesterol embolism has been reported rarely in patients treated with all types of thrombolytic agents; the true incidence is unknown.

Coronary thrombolysis may result in arrhythmias associated with reperfusion. It is recommended that anti-arrhythmic therapy for bradycardia and/or ventricular irritability be available when TNKase is administered.

Please see full Prescribing Information for additional important safety information.

TNKase Dosing and Administration • Investigate the Molecule • Clinical Data • Publications and Resources
Relevant Links • Product Return and Replacement • Full Package Insert • Opt Out • Home • Terms and Conditions • Privacy Policy

Please see TNKase full Prescribing Information. TNKase^® (Tenecteplase). Activase^® (Alteplase, recombinant).